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Abstract
Amphiphysin 2, encoded by BIN1, is a key factor for membrane sensing and remodelling in different cell types. Homozygous
BIN1 mutations in ubiquitously expressed exons are associated with autosomal recessive centronuclear myopathy (CNM), a
mildly progressive muscle disorder typically showing abnormal nuclear centralization on biopsies. In addition, misregulation
of BIN1 splicing partially accounts for the muscle defects in myotonic dystrophy (DM). However, the muscle-specific function
of amphiphysin 2 and its pathogenicity in both muscle disorders are not well understood. In this study we identified and
characterized the first mutation affecting the splicing of the muscle-specific BIN1 exon 11 in a consanguineous family with
rapidly progressive and ultimately fatal centronuclear myopathy. In parallel, we discovered a mutation in the same BIN1
exon 11 acceptor splice site as the genetic cause of the canine Inherited Myopathy of Great Danes (IMGD). Analysis of RNA
from patient muscle demonstrated complete skipping of exon 11 and BIN1 constructs without exon 11 were unable to
promote membrane tubulation in differentiated myotubes. Comparative immunofluorescence and ultrastructural analyses
of patient and canine biopsies revealed common structural defects, emphasizing the importance of amphiphysin 2 in
membrane remodelling and maintenance of the skeletal muscle triad. Our data demonstrate that the alteration of the
muscle-specific function of amphiphysin 2 is a common pathomechanism for centronuclear myopathy, myotonic dystrophy,
and IMGD. The IMGD dog is the first faithful model for human BIN1-related CNM and represents a mammalian model
available for preclinical trials of potential therapies.
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Introduction
Amphiphysin 2 is one of the key factors in muscular membrane
remodeling. The gene, BIN1, has recently been associated with
two different muscle disorders: centronuclear myopathy (CNM,
MIM #255200) [1] and myotonic dystrophy (DM, MIM
#160900 and #602668) [2]. However, the muscle-specific role
of the ubiquitous protein amphiphysin 2 and the pathological
mechanisms underlying the muscle disorders are not well under-
stood. This is mainly due to the lack of faithful animal models.
Centronuclear myopathies are characterized by a generalized
muscle weakness, atrophy, predominance of type I fibers, and
aberrant positioning of nuclei and mitochondria [3]. The different
genetic forms are not or are only moderately progressive. The X-
linked and dominant CNM forms result from mutations in the
phosphoinositide phosphatase myotubularin (MTM1) and the
large GTPase dynamin 2 (DNM2), respectively [4,5]. The
autosomal recessive form (ARCNM) is caused by mutations in
BIN1, probably involving a partial loss-of-function as the protein
level was found to be normal in previously described patients [1].
Amphiphysin 2, encoded by BIN1, contains a N-terminal
amphipathic helix, a BAR (Bin/Amphiphysin/Rvs) domain, able
to sense and maintain membrane curvature, a Myc-binding
domain and a SH3 domain, both implicated in protein-protein
interactions [6,7,8]. There are at least 12 different isoforms,
mainly differing by the presence or absence of a phosphoinositide-
binding domain and a clathrin-binding domain encoded by exon
11 and exons 13–16, respectively [9,10]. The clathrin-binding
PLOS Genetics | www.plosgenetics.org 1 June 2013 | Volume 9 | Issue 6 | e1003430
domain is present in the brain isoforms, while the phosphoino-
sitide-binding (PI) domain is found almost exclusively in skeletal
muscle isoforms [10,11,12]. Sequencing of cDNA demonstrated
that all BIN1 skeletal muscle isoforms contain exon 11 [12]. All
ARCNM mutations described to date are in ubiquitously
expressed exons [1,13,14,15], raising the question about the
molecular basis of the muscle-specificity of the disease. The BAR
domain mutations strongly decreased the amphiphysin 2 mem-
brane tubulating properties when expressed in cultured cells, while
SH3 truncating mutations were shown to impair the binding and
recruitment of dynamin 2 [1].
Mis-splicing of the BIN1 muscle-specific exon 11 was reported
in different forms of myotonic dystrophy (DM) [2]. DM is one of
the most common muscular dystrophies in neonates and adults,
and results from the expression of mutant RNAs with expanded
CUG or CCUG repeats leading to the sequestration of splicing
factors and subsequent defects in RNA splicing. Splicing
alterations of the muscle chloride channel CLCN1 are suggested
to be responsible for the myotonia, whereas aberrant splicing of
the insulin receptor INSR gene is thought to cause insulin
resistance in DM patients. Complete or partial skipping of BIN1
exon 11 in congenital and adult DM was shown to involve
structural T-tubule abnormalities and subsequently muscle weak-
ness [2]. However, there are numerous splicing defects in DM. It is
therefore challenging to assess the exact contribution of BIN1 exon
11 skipping to the DM phenotype, even though severe hypotonia,
respiratory failure and histopathological features such as fiber
hypotrophy and centrally located nuclei in the congenital forms of
DM show intriguing similarities to CNM.
Amphiphysins are key regulators of membrane curvature and
trafficking [16]. They can sense membrane curvature and
presumably promote the curvature and fission of membranes
[17]. Membrane binding occurs via BAR domain dimers,
presenting a positively charged concave site that interacts with
the negative membrane charges [17]. Amphiphysins also bind and
recruit other regulators of endocytosis to sites of plasma membrane
inward budding [18]. Amphiphysin 1 expression is restricted to
neuronal tissues and the protein regulates synaptic vesicle recycling
in the brain [19]. Amphiphysin 2 is highly expressed in adult
striated muscle and its expression increases during muscle cell
maturation [10,11,20,21]. The polybasic residues encoded by
BIN1 exon 11 are required for amphiphysin 2-induced membrane
tubulation when exogenously expressed in cultured cells [1,22]. In
skeletal muscle, amphiphysin 2 is localized at the T-tubules, which
are deep sarcolemmal invaginations enabling excitation-contrac-
tion coupling [11], i.e. the process converting an electrical stimulus
into mechanical muscle work. This specific localization, together
with the membrane tubulation properties of the muscle-specific
isoform containing the PI domain, called iso8 or M-amphiphysin,
has led to the suggestion that amphiphysin 2 is implicated in T-
tubule biogenesis [22]. This is sustained by defects in the
localization of nascent T-tubule markers such as caveolin 3
following BIN1 downregulation in cultured cells [23], and by the
abnormal T-tubule structure seen in drosophila with null mutations
in amph, the unique ortholog of mammalian amphiphysins 1 and 2
[24]. While faithful animal models were previously characterized
for the MTM1 and DNM2 related CNM forms [25], the perinatal
lethality of Bin1-null mice precludes the analysis of the role of
amphiphysin 2 in skeletal muscle [26]. Therefore, critical questions
concerning the muscle-specific function of amphiphysin 2 in
mammals and the pathological mechanism of BIN1-related CNM
remain unanswered. The lack of a faithful animal model for
autosomal recessive centronuclear myopathy is a hurdle for a
better comprehension of the pathological mechanisms and for the
development of therapeutic approaches.
In this study, we identified and characterized the first human
BIN1 mutation affecting the muscle-specific PI domain. We also
identified a novel spontaneous canine model reproducing the
human pathology and allowing investigations on the physiological
role of amphiphysin 2 in skeletal muscle after birth. Characteriza-
tion of the dog model revealed an important role for amphiphysin 2
in triad structure, and we provide the evidence for a physiological
function of the membrane-deforming properties of amphiphysin 2
and its alternative splicing-dependent activity. Our data support
the hypothesis that the alteration of the muscle-specific function of
amphiphysin 2 on membrane remodeling is a common patho-
mechanism underlying several canine and human myopathies.
Results
BIN1 exon 11 splice mutation in patients with rapidly
progressive centronuclear myopathy
To identify BIN1 mutations affecting its function in skeletal
muscle, we sequenced the muscle-specific exon 11 and the
adjacent splice-relevant intronic regions in a cohort of 84 patients
with various forms of centronuclear myopathy and without
mutations in MTM1, DNM2, or in the other BIN1 exons. We
identified a homozygous BIN1 exon 11 splice acceptor mutation
(IVS10-1G.A) in two affected members from a consanguineous
family from Turkey (Figure 1A and 1B). DNA was not available
for the third affected member, who is expected to carry the same
homozygous BIN1 mutation as her monozygotic twin sister. The
parents are healthy and do not present clinical signs of a muscle
disorder. They are first-degree cousins and were found to be
heterozygous for the BIN1 exon 11 splice acceptor mutation,
confirming autosomal recessive inheritance of the disease. The
mutation was not found in unaffected individuals from different
origins, including 37 DNAs from an ethnically matched control
population, and is not listed in the SNP databases as dbSNP, 1000
genomes, or the NHLBI exome variant server.
Patients 1 and 2 are dizygotic twins. Pregnancy and birth, as
well as motor and speech development were normal. General
muscle weakness was diagnosed at 3.5 years. Hypotonia, muscle
weakness (predominantly of the lower limbs), respiratory distress
Author Summary
The intracellular organization of muscle fibers relies on a
complex membrane system important for muscle struc-
tural organization, maintenance, contraction, and resis-
tance to stress. Amphiphysin 2, encoded by BIN1, plays a
central role in membrane sensing and remodelling and is
involved in intracellular membrane trafficking in different
cell types. The ubiquitously expressed BIN1, altered in
centronuclear myopathy (CNM) and myotonic dystrophy
(DM), possesses a muscle-specific exon coding for a
phosphoinositide binding domain. We identified splice
mutations affecting the muscle-specific BIN1 isoform in
humans and dogs presenting a clinically and histopatho-
logically comparable highly progressive centronuclear
myopathy. Our functional and ultrastructural data empha-
size the importance of amphiphysin 2 in membrane remo-
deling and suggest that the defective maintenance of the
triad structure is a primary cause for the muscle weakness.
The canine Inherited Myopathy of Great Danes is the first
faithful mammalian model for investigating other potential
pathological mechanisms underlying centronuclear myop-
athy and for testing therapeutic approaches.
BIN1 Muscle-Specific Defects in Myopathies
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(VC 50%) and loss of motor skills were rapidly progressive and the
twins died from acute pneumonia involving cardiac failure at age 5
and 7, respectively. Patient 3 is the younger brother, and as for his
sisters, pregnancy, birth, motor and speech development were
normal. Age of onset was 3.5 years and the myopathy was highly
progressive, contrasting the slow progression of muscle weakness in
the reported CNM cases with BIN1 mutations in ubiquitous exons
[1,13,14,15]. Patient 3 presented with predominant proximal
muscle weakness of the lower limbs requiring a wheelchair since
the age of 5 years, facial weakness, but no respiratory distress. Eye
movement defects, as seen in the majority of the MTM1, DNM2
and BIN1 patients, were not noted. Deep tendon reflexes were absent
and the patient had progressive contractures in knees and ankles.
Electrophysiological evaluation was normal or showed only unspe-
cific myopathic changes, with normal nerve conduction velocity.
Cardiac defects were not noted and CK levels were normal. Patient
3 is now 9 years old and presented at his last medical exam in
April 2012 with low MRC grades for both upper and lower limbs.
Impact of the human BIN1 mutation on splicing
The BIN1 IVS10-1G.A variation changes the AG acceptor
splice site into AA, and is predicted to impair exon 11 splicing by
various algorithms. The wild-type acceptor site was recognized by
NNSPLICE (score 0.84) and Human Splice Finder (88.5), while no
acceptor splice site was predicted in the mutated sequence. To
confirm an impact on exon 11 splicing, we performed RT-PCR
after RNA isolation from a muscle biopsy of patient 1, amplified a
fragment encompassing exons 10 to 12, and obtained a shorter
product compared to the control (Figure 1C). To analyze the
transcript(s), we cloned the PCR-products and sequenced the
resulting clones. As we and others previously reported, the skeletal
muscle BIN1 isoforms contain exon 11, but lack exons 7 and 13 to
16. Exon 17 can be either present or absent, corresponding to
isoform 8 or M-amphiphysin [10,11,12]. Among the 30 analyzed
clones, only a single clone contained exon 11. Twenty-nine clones
did not contain exon 11 and directly combined exon 10 with exon
12, demonstrating a major skipping of the in-frame exon 11 in the
patient muscle (Figure 1D). The impact of the mutation on the
amphiphysin 2 protein level in skeletal muscle was investigated by
Western blot (Figure 1E). Using an anti-PI domain antibody, we
detected several bands in the control as previously reported [1],
most probably reflecting post-translational modifications of the
different isoforms containing exon 11. In the patient muscle, we
found a significant decrease of the level of the amphiphysin 2
Figure 1. Human BIN1 mutation of the exon 11 acceptor splice site and impact on splicing. (A) Pedigree and (B) Chromatopherogram.
Patients 1 and 3 are homozygous for the IVS10-1G.A mutation, while both parents are heterozygous carriers. DNA from patient 2 was not available.
(C) RT-PCR on mRNA isolated from muscle using primers encompassing BIN1 exons 10–12 demonstrated amplification of a shorter product in patient
1 compared to a healthy control. For the negative control (Ctrl-) PCR was performed without cDNA. (D) Sequencing of the BIN1 cDNA from muscle
demonstrated skipping of BIN1 exon 11 in patient 1. (E) Western blot analysis of patient muscle extracts detected a strong reduction of the
amphiphysin 2 isoforms containing the exon 11 encoded PI-binding domain. The level of amphiphysin 2 detected with an anti-SH3 antibody was
comparable between patient 1 and control.
doi:10.1371/journal.pgen.1003430.g001
BIN1 Muscle-Specific Defects in Myopathies
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isoform containing the PI domain, confirming exon 11 skipping in
most BIN1 muscle transcripts. The amphiphysin levels detected
with the anti-SH3 domain antibody were similar in patient 1 and
control. Together with the genetic data, we conclude that the
rapidly progressive CNM form results from a splice mutation
involving the skipping of the muscle-specific exon 11.
BIN1 exon 11 is required for membrane tubulation in
muscle cells
Previous publications demonstrated the importance of the
amphiphysin 2 PI domain in PtdIns(4,5)P2 binding and membrane
tubulation [1,2,22].We transfected C2C12 cells with BIN1 constructs
including or excluding exon 11, and we induced the differentiation
of the murine myoblasts into myotubes. Myotubes expressing the
exon 11 containing isoform showed tubulation [22,27], whereas
the isoform without exon 11 did not induce this effect (Figure 2).
Quantification revealed statistical significance. Immunolabelling
of actin, caveolin-3 and RYR1 did not reveal obvious differences
between the differentially transfected myotubes (data not shown),
suggesting that the amphiphysin 2 PI domain is important for
late muscle development or maintenance, rather than for early
muscle development. This hypothesis is supported by the fact that
the patients were unaffected at birth and during early childhood.
BIN1 exon 11 splice mutation causes the canine Inherited
Myopathy of Great Danes (IMGD)
The perinatal lethality of Bin1-null mice precludes investigations
on the role of amphiphysin 2 in skeletal muscle maintenance [26].
To identify and characterize an animal model for BIN1-related
CNM, we analyzed canine pedigrees with molecularly unsolved
myopathies. The canine Inherited Myopathy of Great Danes
(IMGD) is characterized by rapidly progressive muscle atrophy
and exercise intolerance with an age of onset of about 6 months.
Histological examinations of muscle biopsies from autosomal
recessive cases from the UK, Canada and Australia revealed
increased nuclear internalization and centralization [28,29,30],
consistent with centronuclear myopathy. We excluded mutations
in MTM1 [31] and PTPLA [32] before sequencing the coding
regions and intron/exon boundaries of the canine BIN1 gene
(XM_540990.3). We identified a homozygous AG to GG substitu-
tion of the BIN1 exon 11 acceptor splice site in five dogs from
Canada, US and UK (IVS10-2A.G; Figures 3A and 3B). CK
values for the dogs were normal or slightly elevated. Pedigree
reconstruction revealed a distant relationship between the US and
one UK dog (Figure 3C) and a previous publication reported a
common ancestor for all IMGD dogs in the UK [29]. The BIN1
IVS10-2A.G mutation was not found in 112 healthy Great
Danes and in 35 dogs from 12 other breeds, strongly suggesting its
pathogenicity.
Impact of the canine BIN1 mutation on exon 11 splicing
Like the human BIN1 IVS10-1G.A mutation, the canine BIN1
IVS10-2A.G variation affects the exon 11 acceptor splice site. To
assess its impact on splicing, we performed RT-PCR on RNA
isolated from skeletal muscle biopsies and found a strong reduction
of the BIN1 RNA level compared to healthy controls and
compared to a control gene (MTM1, Figure 3D). We however
detected a faint signal of expected size and cloned the amplicon.
All three clones contained exon 11 with 27 additional upstream
nucleotides, encoding the amino acid sequence ASASRPFPQ
(Figure 3E). This in-frame extension results from the disposition of
a weak cryptic 59 acceptor site. The intronic sequence upstream of
exon 11 slightly differs between human and dog, possibly
explaining the cryptic splicing in dogs versus exon skipping in
human patients (Figure 3F). To confirm the impact of the splice
mutation on the amphiphysin 2 protein level, canine muscle
extracts were probed with an anti-PI domain antibody on Western
blot. Compared to the healthy control, amphiphysin 2 was
significantly reduced in the affected dog (Figure 3G). Using an
anti-SH3 antibody we detected a strong reduction of all skeletal
muscle amphiphysin isoforms (Figure S1) in accordance with the
RT-PCR data. We conclude that the canine Inherited Myopathy
of Great Danes results from a BIN1 exon 11 splice mutation,
provoking a strong reduction of the exon 11/PI domain-
containing RNA and protein.
Similar histopathology in affected humans and dogs
Vastus lateralis muscle biopsies were performed for patient 1
as well as for patient 3 at the age of 3.5 years. H&E staining
revealed prominent nuclear centralization (.60%, arrow), fiber
atrophy and endomysial fibrosis (Figure 4), consistent with centro-
nuclear myopathy. Similarly, H&E staining of biceps femoris
muscle biopsies from affected dogs revealed nuclear internalization
(.40%) and fiber atrophy. The central areas devoid of staining
reflect perinuclear regions lacking myofibrils. Of note, the trans-
verse muscle sections of patients and affected dogs showed an
unusual lobulated appearance with indentations of the sarcolemma
(arrowheads). NADH staining of human and canine sections
revealed dense central areas in most fibers and ‘‘spoke of wheel’’
appearance in 5% of the fibers. ATPase staining showed no or
only a slight predominance of type I muscle fibers as compared to
the age matched controls. Gomori trichrome staining did not
reveal any further abnormalities (data not shown). Taken together,
human and canine histopathologies were comparable.
Common ultrastructural and membrane defects in
affected patients and dogs
To uncover the pathological defects underlying this highly
progressive form of centronuclear myopathy and to validate the
canine model, we analyzed human and dog muscle biopsies by
electron microscopy. Ultrastructural analysis of the human muscle
biopsy revealed centralized nuclei surrounded by an area devoid of
myofibrils and containing glycogen granules and other organelles
(Figure 5A, Figure S2), as commonly seen in MTM1, DNM2 and
BIN1-related CNM. Myofibrillar disintegration with occasional Z-
band streaming (arrow, Figure 5A) was seen in the adjacent
sarcomeres. Triad structures were found to be aberrant and we
observed frequent enlarged structures, most probably originating
from the sarcoplasmic reticulum (arrow, Figure 5D). We also
noted other membrane alterations, including accumulations of
membranes and tubules, vacuoles containing whorled membranes
(arrow, Figure 5B), as well as a high number of myelin-like
membranous structures suggestive of autophagosomes (arrow,
Figure 5C). Likewise, ultrastructural analysis of muscle biopsies
from an affected Great Dane dog showed nuclear internalization,
mitochondrial accumulations around the internalized nuclei and
myofibrillar disarray (Figure 5E, Figure S3). We furthermore
found membranous whorls (arrow, Figure 5F) as reported for the
X-linked CNM Labrador retriever model with MTM1 mutation
[31], deep membrane invaginations (arrowhead, Figure 5F),
lipofuscin granules (arrow, Figure 5G), and abnormal triads in
almost all fibers (arrow, Figure 5H). Sarcolemmal invaginations
contained basement membranes and often pointed towards
centralized nuclei. Taken together and considering the histological
analysis described above, histopathology of IMGD dogs and
human patients appear strikingly similar, emphasizing common
alterations of membrane structures.
BIN1 Muscle-Specific Defects in Myopathies
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Amphiphysin 2 is present but altered in affected human
and dog muscles
To further characterize the pathophysiology of the rapidly
progressive human CNM and canine IMGD, we performed
immunolocalization experiments on muscle biopsies. Using the
R3062 antibody recognizing most amphiphysin isoforms or the PI-
domain specific R2405 antibody, signals were detected as an
intracellular network in transverse sections of human and canine
Figure 2. Essential role of BIN1 exon 11 in membrane tubulation in myotubes. C2C12 myotubes overexpressing BIN1 isoform 8 (including
exon 11) showed strong tubulation, whereas BIN1 isoform 9 (without exon 11) does not induce membrane tubulation 5 days post differentiation.
Below: quantification of three independent experiments (.30 myotubes each) demonstrated that these findings were significant (p,0.01).
doi:10.1371/journal.pgen.1003430.g002
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Figure 3. The canine Inherited Myopathy of Great Danes results from a BIN1mutation in the exon 11 acceptor splice site. (A) Picture
of an affected 3-year-old Great Dane dog. (B) Chromatopherograms and sequence alignment showing the BIN1 IVS10-2A.G mutation in 5 affected
dogs. (C) Pedigree showing the distant relationship of two affected Great Dane dogs from the UK and US. (D) RT-PCR on skeletal muscle RNA showed
a strong reduction of the BIN1 RNA level in the IMGD dog compared to the healthy canine control. Amplification of a control gene (MTM1) was
normal. M=Marker (E) Sequencing of the residual cDNA revealed the presence of 27 additional nucleotides due to the use of a weak cryptic 59 splice
acceptor site. (F) Sequence alignment of human and canine BIN1 intron/exon boundary of exon 11. (G) Western blot using an anti-PI domain antibody
showed a strong decrease of the amphiphysin 2 protein level.
doi:10.1371/journal.pgen.1003430.g003
BIN1 Muscle-Specific Defects in Myopathies
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controls (Figure 6). Signals were also detected in sections of
muscles from patient and affected dog, reflecting the presence of
different amphiphysin 2 isoforms as shown by Western blot.
Despite the decrease of BIN1 RNA in affected dogs, the remaining
mis-spliced in-frame transcripts can explain the detection of
amphiphysin 2 on muscle sections, especially because immuno-
histochemistry is not quantitative. The amphiphysin 2 network
appeared however abnormal in patient and IMGD sections. In
some fibers we noted central areas without any signal, while in
other fibers accumulations around centralized nuclei were
observed (arrows). To determine whether these anomalies were
specific for the BIN1 exon 11 splice mutation or rather a general
BIN1-related CNM feature, we analyzed a muscle biopsy from a
patient with the previously reported BIN1 p.Asp151Asn mutation
and a classical ARCNM phenotype [1]. We observed similar
accumulations of amphiphysin 2 (Figure 6A), suggesting that
different BIN1 mutations in humans and dogs lead to similar
amphiphysin 2 mis-localization in muscle.
Alteration of triad and membrane trafficking regulators
Amphiphysin 2 has been proposed to be implicated in T-tubule
biogenesis, but the exact link has barely been documented in
mammalian skeletal muscle [22]. We therefore examined the
skeletal muscle triad using antibodies against the junctional
sarcoplasmic calcium channel RYR1 and the T-tubule marker
DHPR in human and dog (Figure 7). Both proteins were profoundly
altered, showing focal accumulations or central areas without signal
in the fibers. Compared to the control longitudinal sections, the
transversal orientation of RYR1-labeled triads was lost in patient
and canine muscle. Similarly, the longitudinal sarcoplasmic calcium
pump SERCA1 was mislocalized in sections from affected dogs.
We next wanted to know whether the aberrant triad structure
was concurrent with more generalized membrane defects. Dysferlin
and caveolin 3, key regulators of membrane repair and traffick-
ing [33,34], were found to be mainly located at the sarcolemma
in control muscle sections. In contrast, transverse sections of
patient 1 and of an affected Great Dane dog revealed striking
intracellular accumulations of dysferlin, mainly around central
nuclei (Figure 7). Labeling of the sarcolemmal markers dysferlin,
caveolin 3 and dystrophin confirmed the presence of numerous
fibers with unusual lobulated and indented sarcolemma,
representing deep sarcolemmal invaginations pointing towards
the center of the fibers (arrows, Figure 7). Taken together, our
data correlate the highly progressive human CNM and canine
IMGD with general membrane alterations at the triad, the
sarcolemma and within the fibers. However, these defects did
not reflect a general disorganization of the sarcomere, as alpha-
actinin labeling appeared largely normal (not shown). Staining
of developmental myosin revealed no difference between
affected and control dogs, indicating that there is no excessive
fiber regeneration in IMGD dogs (Figure S3).
Altered myotubularin localization in BIN1-mutated
canine muscles
As MTM1 is mutated in X-linked human and canine CNM, we
investigated the localization of myotubularin in muscle sections of
IMGD dogs. Myotubularin formed an intracellular network in
control sections and the signal was stronger in type II fibers labeled
with the SERCA1 antibody (Figure 8). In both analyzed IMGD
muscles, myotubularin was mainly located as concentric strands
pointing to the center in both type I and type II fibers. We
conclude that altered splicing of BIN1 has a strong impact on
Figure 4. Histopathological comparison of muscles from human patient and IMGD dog. Human and canine muscle biopsy sections
revealed nuclear centralization (arrows), fiber atrophy and lobulation as well as sarcolemmal invaginations (arrowheads) on H&E staining. NADH-TR
staining demonstrated central dense areas in many fibers and ‘‘spoke of wheel’’ appearance in a few fibers (white arrow). ATPase staining (pH 4.3)
revealed no or only a slight predominance of type I fibers compared to the age-matched controls.
doi:10.1371/journal.pgen.1003430.g004
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myotubularin localization in muscle, revealing a potential link
between IMGD and X-linked CNM.
Discussion
In this study we identified and characterized BIN1 mutations
affecting the splicing of the muscle-specific exon 11, resulting in a
rapidly progressing myopathy in humans and dogs. The IMGD
dog is the first faithful mammalian model for BIN1-related
centronuclear myopathy and particularly for the highly progres-
sive form, and is the only characterized mammalian model
available for preclinical trials of potential therapies for this severe
congenital myopathy. Our data provide strong evidence for
muscle-specific functions of amphiphysin 2 in membrane struc-
Figure 5. Common ultrastructural and membrane defects in affected human and dog. (A–D) Electron microscopic analysis of a patient
biopsy showing a centralized nucleus surrounded by organelles and mild sarcomeric disarray (arrow, A), accumulations of membranes and vacuoles
containing whorled membranes (arrow, B), autophagic vacuoles containing myelin-like material (arrow, C), and widened tubules at the triads (arrow,
D). The inset shows normal triads in an age-matched biopsy. (E–H) Ultrastructural analysis of a IMGD dog biopsy revealed central nuclei surrounded
by mitochondrial accumulations (E), membranous whorls (arrow, F), deep membrane invaginations (arrowhead, F), lipofuscin granules (arrow, G), and
abnormal triads (arrow, H). The inserted picture shows a normal triad in an age-matched canine control.
doi:10.1371/journal.pgen.1003430.g005
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Figure 6. Amphiphysin 2 is present but altered in muscles from affected humans and dogs. (A) Amphiphysin 2 localization in control
(left), patient 1 (middle) and a CNM patient with the p.Asp151Asn mutation (right). Arrows indicate abnormal accumulations of amphiphysin 2
around centralized nuclei in both patient muscles. (B) Abnormal localization of amphiphysin 2 on transversal and longitudinal muscle sections from
an IMGD dog compared to a control. The secondary without the primary antibody was applied on control canine sections to withdraw non-specific
background staining.
doi:10.1371/journal.pgen.1003430.g006
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Figure 7. Alteration of triad components and proteins regulating membrane trafficking. Immunolocalization on longitudinal and
transversal sections from patients and affected dogs revealed an abnormal pattern of the junctional sarcoplasmic calcium channel RYR1, the T-tubule
marker DHPR and the longitudinal sarcoplasmic calcium pump SERCA1. Especially RYR1 was found to accumulate around internalized nuclei.
Intracellular dysferlin signals were detected in patients and affected dogs, but not in the age-matched controls. Labeling of the sarcolemmal markers
caveolin 3 and dystrophin demonstrated prominent lobulation and deep indentations of the plasma membrane in patients and affected dogs on
transversal and longitudinal sections (arrows).
doi:10.1371/journal.pgen.1003430.g007
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tural organization and remodelling and allow novel insights into
the overlapping pathogenesis of centronuclear myopathy and
myotonic dystrophy. A schematic representation of the amphi-
physin 2 protein domains and of the position of the mutations and
splicing alterations causing classical autosomal recessive centro-
nuclear myopathy, rapidly progressive human CNM and canine
IMGD as well as myotonic dystrophy is shown in Figure 9.
BIN1 mutations in classical and highly progressive
centronuclear myopathies
Classical BIN1-related ARCNM has been described with
neonatal or childhood onset, hypotonia and ptosis and all
mutations were found in ubiquitously expressed exons
[1,13,14,15]. The muscle weakness was mildly to moderately
progressive, and some patients could still walk at older age. In
contrast, our patients with a splice mutation affecting the muscle-
specific exon 11 showed a rapid disease progression involving
strong care-dependence and leading to death within a few years,
despite normal motor development and disease-onset not before
3.5 years. The histopathological findings of our patients and of the
previously reported ARCNM cases partially overlap, including
atrophy, prominent nuclear internalization and central dense
areas upon NADH-TR staining of muscle sections. However,
there is no evidence for type I fiber predominance in the muscle
biopsies of our patients. Previous RT-PCR experiments demon-
strated a progressive integration of exon 11 in BIN1 mRNA during
human skeletal muscle development [2]. We therefore hypothesize
that the muscle-specific exon 11 plays a major role in muscle
maintenance, rather than in early muscle development. This is in
accordance with the highly progressive phenotype of humans and
dogs with a disease onset several months or years after birth.
Consistently, we detected amphiphysin 2 in muscle tissue, but
RNA analysis revealed major skipping of BIN1 exon 11. This
suggests that the patients mainly express an embryonic BIN1
isoform, which might not be able to assume the function of the
adult BIN1 isoform, possibly explaining the more progressive
phenotype compared to patients with BIN1 mutations in the
ubiquitously expressed exons.
The canine Inherited Myopathy of Great Danes is a
faithful model for BIN1-related centronuclear myopathy
The characterization of the pathological mechanisms leading to
BIN1-related CNM and the development of potential therapeutic
approaches is obviated by the lack of a faithful animal model. Bin1-
Figure 8. Myotubularin is mis-localized in IMGD muscle. In muscle sections from control dogs, myotubularin is predominantly expressed in
type II fibers expressing SERCA1. In affected IMGD dogs, massive myotubularin accumulations formed a concentric network around the fiber center.
doi:10.1371/journal.pgen.1003430.g008
Figure 9. Schematic representation of the amphiphysin 2 domains and BIN1 alterations in different myopathies. Schematic
representation of the amphiphysin 2 protein domains and position of the known mutations causing autosomal recessive centronuclear myopathy,
the new splice mutations resulting in rapidly progressive centronuclear myopathy and canine Inherited Myopathy of Great Danes. Myotonic
dystrophy induces mis-splicing of BIN1 exon 11. Nomenclature is based on isoform 1 (NM_139343).
doi:10.1371/journal.pgen.1003430.g009
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null mice are perinatally lethal [26], so that a comprehensive
analysis of skeletal muscle alterations during disease development
is not possible. We sought for dog breeds with molecularly
unsolved congenital myopathies and we identified the canine
Inherited Myopathy of Great Danes as a disease model repro-
ducing the histological and physiological defects observed in BIN1-
related CNM patients. IMGD has been reported for cases in
Canada, Australia and UK and is characterized by generalized
muscle atrophy, exercise intolerance, exercise-induced tremor and
muscle wasting [29]. The disease typically starts before 10 months
of age, is highly progressive, and most of the affected dogs are
euthanized before 18 months of age due to severe debilitating
muscle weakness. Histological examinations revealed internalized
or central nuclei without evidence of inflammation, disruption of
the sarcomeric architecture with central fiber areas devoid of
myofibrils, and central accumulations of mitochondria and
glycogen granules ([28,29,30] and our data). In addition, type I
fiber predominance in combination with an increased expression
of genes implicated in the slow-oxidative metabolism was described
[35]. In this study we demonstrate that IMGD and progressive
CNM have a comparable etiopathology and both conditions result
from mutations of the AG acceptor splice site of the BIN1 muscle-
specific exon 11. The histopathology and the cellular organization
defects of the human and canine muscle disorders are almost
identical, we therefore consider IMGD as a faithful mammalian
model for BIN1-related centronuclear myopathy.
Veterinary implications
Some dogs of our IMGD cohort were found to be negative for
BIN1 mutations, suggesting that IMGD encompasses several
disorders with similar clinical and overlapping histopathological
features. The proven relationship of two affected Great Dane dogs
demonstrates a common origin of the BIN1 exon 11 splice
mutation, and it is likely that all five affected dogs described here
can be traced back to a common ancestor. As the muscle disorder
is inherited as a recessive trait, and as canine pedigrees are
generally highly inbred, it is likely that the mutation can be found
in Great Dane dog populations from all over the world, as recently
demonstrated for another autosomal recessive CNM form in
Labrador retrievers [36]. It is therefore of veterinary medical
interest to sequence BIN1 exon 11 in Great Dane dogs. Also,
veterinarians and veterinary pathologists should consider BIN1
mutations as a possible cause of any unexplained progressive
myopathy in dogs, especially when the biopsy displays internal
nuclei and lobulated or indented sarcolemma.
Insights into amphiphysin 2 muscle-specific functions
and pathological mechanisms of centronuclear
myopathy
Detailed immunohistochemical and ultrastructural analyses of
muscles from patients and affected Great Dane dogs revealed
common membrane alterations and abnormal accumulations of
proteins regulating membrane trafficking. Similar findings were
observed on biopsies from patients with DNM2 or MTM1
mutations [12], suggesting that mislocalization of triad proteins
reflects common aberrations in CNM and that the amphiphysin 2
muscle-specific isoform plays an important role in triad formation
and/or maintenance. This is in accordance with the known
biochemical function of amphiphysin 2 and other N-BAR domain
proteins to sense membrane curvature and to potentially induce
curvature through the insertion of an amphipathic helix into the
membrane bilayer. In vitro and cell culture experiments have led
to the suggestion that the exon 11 encoded PI-binding motif is
essential for membrane tubulation in cultured muscle cells [22].
Indeed, Drosophila mutated for amphiphysin, the ortholog of both
amphiphysin 1 and amphiphysin 2, display an abnormal T-tubule
system [24]. T-tubule alterations and muscle weakness were
reproduced in murine Tibialis anterior injected with a U7 small
nuclear RNA construct harboring an antisense sequence promot-
ing BIN1 exon 11 skipping [2]. However, nuclear centralization
and atrophy were not observed, contrasting with the IMGD
model. This difference might be species-related, is possibly due to
a low efficacy of the AAV-U7 method or alternatively to the
examination time point 4 months post injection. As the triad is the
membrane structure controlling excitation-contraction coupling,
this suggests that impaired excitation-contraction coupling and
subsequent calcium homeostasis defects are a primary cause of the
myopathy. Of note, abnormal intracellular calcium release was
observed in isolated murine muscle fibers after BIN1 shRNA-
mediated knock-down [37]. Together with the present character-
ization of the IMGD model, these data indicate that amphiphysin
2 has an important muscle-specific role in triad structural
maintenance, and provide additional evidence that triad modifi-
cations are a common defect in centronuclear myopathies, IMGD
and myotonic dystrophies [2,12].
Triads are not the only membrane compartment affected in
patients and dogs harboring BIN1 exon 11 mutations. We also
noted central accumulations of caveolin 3 and dysferlin, two key
regulators of membrane trafficking in skeletal muscle, numerous
membranous whorls, and a peculiar remodeling of the sarcolem-
ma, manifesting an indented fiber perimeter and invaginations
towards the center of the fibers. Caveolin 3 regulates membrane
tension at the sarcolemma and dysferlin controls membrane
exocytosis in sarcolemmal membrane repair [33,34]. As both
proteins are also present on regenerating T-tubules [38], their
mislocalization resulting from a BIN1 mutation would be in
accordance with defective T-tubule regeneration. Moreover, data
mainly obtained in cultured cells support a key role of
amphiphysins in the formation of endocytic vesicles [16], and a
study in Caenorhabditis elegans suggested a role of amphiphysin in
vesicle recycling [39]. Defects in intracellular signaling resulting
from calcium defects and impaired transport of ion channels and
growth factor might explain the muscle weakness and atrophy in
BIN1-related CNM.
Amphiphysin 2 links several forms of centronuclear
myopathies and myotonic dystrophy
Our findings on the IMGD model uncovered possible links
between BIN1-related and other forms of CNM. Altered triads and
the presence of membranous whorls were reported for MTM1
dog, mouse and zebrafish models as well as for patients with
MTM1 mutations involving protein loss [12,31,40,41,42]. Abnor-
mal triad markers were also reported for MTM1-related and
DNM2-related CNM [12,43]. Dysferlin localization was not
extensively studied in MTM1-CNM but was increased in the
cytoplasm of a mouse model and in patients with DNM2-CNM
[44]. Moreover, we found myotubularin localization was strongly
impaired in IMGD muscles. These findings suggest that
myotubularin and amphiphysin 2 are in the same pathway
regulating membrane remodeling in skeletal muscle and strength-
en the hypothesis of a common pathological mechanism of the X-
linked and the autosomal recessive CNM forms.
Alternative splicing of BIN1 exon 11 is mis-regulated in patients
with myotonic dystrophy [2]. The parallel inclusion of exon 7 was
noted, but its impact has not been assessed yet. Here we report the
first mutation affecting the muscle-specific exon 11 of BIN1 and
having an impact on splicing. The major clinical and histological
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aspects of the patients and IMGD dogs include general muscle
weakness, atrophy and nuclear centralization, consistent with the
muscle phenotype in DM patients. Our data therefore support the
hypothesis that mis-splicing of BIN1 exon 11 partially accounts for
the muscle-specific signs in myotonic dystrophy.
Materials and Methods
Ethics statement
Human sample collection was performed with informed consent
from the patients according to the declaration of Helsinki and
experimentation was performed as part of routine diagnosis. All
dogs were examined with the consent of their owners. Blood and
biopsies were obtained as part of routine clinical procedures for
diagnostic purposes. Cheek cells were collected by owners or
veterinarians using non-invasive swabs. As the data were from
client-owned dogs undergoing normal veterinary exams, there was
no ‘‘animal experiment’’ according to the legal definitions in
Europe and the US. All local regulations related to clinical
procedures were observed. Cryopreserved muscle specimens were
processed and stored at the University of California, San Diego,
under a tissue transfer approval from the institutional Animal Care
and Use Committee.
Molecular genetics
Human Genomic DNA was prepared from peripheral blood by
routine procedures and sequenced for all coding exons and
intron/exon boundaries of MTM1, DNM2, and BIN1 as described
elsewhere [1,4,5]. Patient 1 had a normal CTG repeat length at
the DMPK locus (7 and 13 repeats) and was therefore excluded for
myotonic dystrophy. Control DNAs were from healthy individuals
of Turkish origin.
Dog DNA samples were extracted from cheek cells, venous
blood or muscle biopsy specimens (cryosections or paraffin
embedded tissue) by routine procedures and sequenced for all
coding exons and intron/exon boundaries of canine MTM1 [31],
PTPLA [32] and BIN1 (primer sequences in Table S1). Control
samples were from a world-wide collection of healthy Great Danes
as well as from healthy individuals of 13 other breeds.
RNA studies
RNA was extracted from muscle biopsies by routine proce-
dures and reverse transcribed using the SuperScript III kit
(Invitrogen, Carlsbad, USA). Human and dog amplicons were
cloned into the pGEM-T Easy vector (Promega, Madison, USA)
and transfected into E.coli DH5a cells. Blue/white selection,
repeated twice, resulted in 30 clones for the human cDNA and 3
clones for the canine cDNA. Control dog was an unaffected
Drahthaar (German Wirehaired Pointer). Primer sequences are
listed in Table S1.
Protein studies
Western blot and immunofluorescence were performed using
routine protocols. Biceps femoris and tibialis anterior biopsies from
two affected dogs (14 months and 22 months, respectively) and
from healthy age-matched Golden Retrievers or Belgian Shep-
herds as controls have been used for the analysis. Following
antibodies were used for the study: R2406 (home-made rabbit
anti-BIN1 PI binding domain), R2444 (home-made rabbit anti-
BIN1 SH3 domain), R3062 (home-made rabbit anti-BIN1 exon
12 epitope), R2867 and R2868 (home-made rabbit anti-MTM1),
mouse anti-GAPDH (Merck Millipore, Darmstadt, Germany),
mouse anti-ryanodine receptor 1 (Affinity BioReagents, Golden,
USA), mouse anti-SERCA 1 (Affinity BioReagents, Golden, USA),
rabbit anti-dysferlin (Euromedex, Souffelweyersheim, France),
goat anti-caveolin-3 (Tebu-BIO, Le-Perray-en-Yvelines, France),
rabbit anti-caveolin-3 (Affinity BioReagents, Golden, USA), mouse
anti-DHPR (Affinity BioReagents, Golden, USA), and mouse anti-
dystrophin (Leica Microsystems, Germany). For immunohisto-
fluorescence, transverse cryosections were prepared, fixed and
stained by routine methods. Nuclei were stained with Hoechst or
DAPI (Sigma-Aldrich, St. Louis, USA). Sections were mounted
with slowfade antifade reagent (Invitrogen, Carlsbad, USA) and
viewed using a laser scanning confocal microscope (TCS SP2;
Leica Microsystems, Wetzlar, Germany) or a a Zeiss Axio
Observer Z.1 microscope equipped with a 206, 406or 636 lens
and Axioplan imaging with structured illumination (Carl Zeiss,
Jena, Germany).
Muscle histology
For histochemical analyses, transverse sections of muscle
cryosections (8 mm) of vastus lateralis and biceps femoris muscle
biopsies were stained with hematoxylin-eosin, modified Gomori
trichrome, NADH-TR and myofibrillar ATPase and then assessed
for centralized nuclei, fiber morphology, fiber type distribution,
cores, protein accumulation and cellular infiltrations.
Electron microscopy
Muscle biopsies were processed for electron microscopy as
described previously [45]. Briefly, the tissue was fixed either in 6%
phosphate-buffered glutaraldehyde (human patient) or in 2.5%
paraformaldehyde, 2.5% glutaraldehyde, and 50 mM CaCl2 in
0.1 M cacodylate buffer at pH 7.4 (dog), and post-fixed with 2%
OsO4, 0.8% K3Fe(CN)6 in 0.1 M cacodylate buffer (pH 7.4) for
2 h at 4uC and incubated with 5% uranyl acetate for 2 h at 4uC.
Samples were dehydrated in graded series of ethanol and
embedded in epoxy resin 812. Ultrathin sections (70 nm) were
contrasted with uranyl acetate and lead citrate.
Membrane tubulation assay
Murine C2C12 myoblasts were seeded on coverslips and
transfected at 50–60% confluency using Lipofectamine 2000
(Invitrogen, Carlsbad, USA) either with GFP-BIN1 isoform 8
(including exon 11) or isoform 9 (excluding exon 11, both were a
kind gift from Pietro de Camilli, Howard Hughes Medical
Institute, USA). Cells were differentiated after 24 h by changing
to medium containing 2% horse serum instead of FCS and fixed
and stained after 5 days of differentiation by routine methods.
Nuclei were stained with Hoechst/DAPI (Sigma-Aldrich, St.
Louis, USA) and sections were mounted with slowfade antifade
reagent and viewed using a laser scanning confocal microscope
(TCS SP2; Leica Microsystems, Wetzlar, Germany).
Web resources
1000 genomes - A Deep Catalog of Human Genetic Variation
(URL: http://www.1000genomes.org/)
Database of Single Nucleotide Polymorphisms (dbSNP).
Bethesda (MD): National Center for Biotechnology Information,
National Library of Medicine. (dbSNP Build ID: 134).
(URL: http://www.ncbi.nlm.nih.gov/SNP/)
Exome Variant Server, NHLBI Exome Sequencing Project
(ESP), Seattle, WA (URL: http://evs.gs.washington.edu/EVS/)
Online Mendelian Inheritance in Man (OMIM) (URL: http://
www.omim.org/)
NNsplice: prediction of splice mutations (URL: http://www.
fruitfly.org/seq_tools/splice.html)
Human Splicing finder (URL: http://www.umd.be/HSF/)
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Supporting Information
Figure S1 Western blot of canine muscle extracts using the anti-
SH3 domain antibody. Compared to the control, the main skeletal
muscle amphiphysin 2 isoform is strongly reduced in the IMGD
dog. The protein levels of the other isoforms are also reduced, but
still detectable.
(TIF)
Figure S2 Low-magnitude electron microscopy pictures of
muscles from patient 1 and an affected dog demonstrate moderate
Z-band streaming, mitochondrondrial accumulations and myofi-
brillar disarray.
(TIF)
Figure S3 Dog muscle sections labeled for developmental
myosin. Signals were comparable in affected dog and control,
suggesting that there is no excessive fiber regeneration.
(TIF)
Table S1 Primer sequences.
(XLSX)
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